Kevin LaBar, Ph.D., Sept 26, 2018
"An Information Mapping Approach to Emotion Representation in the Brain”

William K. Warren, Jr.  Frontiers in Neuroscience Lecture 
Laureate Psychiatric Clinic and Hospital Conference Center 
11:00 am - 11:45 am    Registration and Lunch, lunch stops being served at 11:45 - no exceptions
12:00 pm - 1:00 pm     Program

Kevin S. LaBar is a Professor in the Center for Cognitive Neuroscience and Department of Psychology & Neuroscience at Duke University. He earned his Ph.D. at New York University and completed postdoctoral studies at Yale University. He was an Instructor of Neurology at Northwestern University Medical School prior to joining the Duke faculty in 1999. His research seeks to understand how emotions are processed in the brain and how they bias cognitive functions. He addresses these questions using behavioral, psychophysiological, neuroimaging, and patient-based research approaches. Dr. LaBar received Young Investigator awards from the National Alliance for Research on Schizophrenia and Depression, Oak Ridge Associated Universities, and the Cognitive Neuroscience Society, as well as a CAREER award from the National Science Foundation. He was elected Fellow of the Association for Psychological Science in 2010 and received the honorary Frijda Chair in Cognitive Sciences from the University of Amsterdam in 2012. Dr. LaBar serves as Deputy Editor for neuroscience content in Science Advances, the on-line extension of Science magazine. He has published over 150 journal articles and book chapters, and is a senior editor and co-author of the Sinauer textbook Principles of Cognitive Neuroscience. His work is currently funded by the National Science Foundation and the National Institutes of Health. 
 
Learning objectives: 

1. To know the conceptual differences among prominent psychological theories of emotion.
2. To learn how machine learning tools can be applied to study the representation of specific emotions in the brain.
3. To understand how advanced neuroimaging tools can decode patterns of spontaneous emotion from resting-state fMRI data.

Sonja Lyubomirsky, Ph.D., August 7, 2018

"The How, What, and Why of Happiness:  The Science of Interventions Aimed at Increasing Well-Being”

William K. Warren, Jr.  Frontiers in Neuroscience Lecture 
Laureate Psychiatric Clinic and Hospital Conference Center 
11:00 am - 11:45 am    Registration and Lunch, lunch stops being served at 11:45 - no exceptions
12:00 pm - 1:00 pm     Program

Sonja Lyubomirsky, Ph.D., is Professor and Vice Chair of Psychology at the University of California, Riverside and author of The How of Happiness and The Myths of Happiness, translated 28 countries, respectively. She received her B.A. summa cum laude from Harvard University and her Ph.D. in social psychology from Stanford University.  Lyubomirsky’s teaching and mentoring of students have been recognized with the Faculty of the Year (twice) and Faculty Mentor of the Year Awards.  Her research – on the possibility of lastingly increasing happiness — have been the recipients of many honors, including the the Distinguished Research Lecturer Award, a Templeton Positive Psychology Prize, a Psychology & Philosophy grant, a Science of Generosity grant, and several John Templeton Foundation grants.  Lyubomirsky lives in Santa Monica, California, with her husband and four kids, ages 5 to 19.

Learning objectives: 

1. Participants will describe one empirical research example showing how the experience of frequent positive emotions benefits relationships, work, and health.
2. Participants will list three intentional activities that have been shown to increase happiness, and describe at least one study that supports the efficacy of each of these three activities.
3. Participants will list three factors that moderate (or impact) the success of activities aimed at increasing happiness.

For Physicians: CME credit will be given.

For Psychologists: The Oklahoma State Board of Examiners of Psychologists, the American Psychological Association and the Oklahoma Psychological Association recognizes AMA PRA Category 1 credit™.  

For Social Workers: This event has been approved by the Oklahoma State Board of Licensed Social Workers for 1 hour Category 1Clinical.  (CEP Number - 20150007)

For LPCs and LMFTs: An application has been made to the State Board of Behavioral Health Licensure (BBHL) for 1 hour of CE.

For CADCs and LADCs: Laureate Psychiatric Clinic and Hospital, Tulsa, Oklahoma, is accredited as a provider of continuing chemical dependency education by the State of Oklahoma - Board of Licensed Alcohol and Drug Counselors for 1 hour of CE.                                     
REGISTER TO ATTEND!

To register, email:  Lauren Haguewood at lehaguewood@saintfrancis.com
​

In November 2016, LIBR organized the Interoception Summit, a first of its kind gathering of interoception experts from around the world. The primary output of this gathering is the white paper “Interoception and Mental Health: A Roadmap” published yesterday in the attached Interoception special issue of Biological Psychiatry: Cognitive Neuroscience and Neuroimaging. The special issue highlights several new and exciting ways in which interoceptive science is impacting mental health. The articles (several by LIBR investigators) span a diverse set of approaches including functional neuroimaging, psychophysiology, novel behavioral interventions, and a detailed examination of the link between interoception and inflammation.
 
This special issue is a great representation of LIBR’s impact on the interoception field. Congratulations to everyone who contributed to this exciting new publication!

Dr. Charles Raison: April 3rd, 2018
"Evolution Comes to the Clinic: Relevance of Ancient Practices for 21st Century Mental Health"

William K. Warren, Jr. Frontiers in Neuroscience Lecture
Laureate Psychiatric Clinic and Hospital Conference Center
11:00am - 11:45 am    Registration and Lunch, lunch stops being served at 11:45 - no exceptions
12:00pm - 1:00pm     Program

Charles Raison, MD, is the Mary Sue and Mike Shannon Chair for Healthy Minds, Children & Families and Professor, School of Human Ecology, and Professor, Department of Psychiatry, School of Medicine and Public Health, University of Wisconsin-Madison in Madison, WI. He also serves in a consultant role as Director of Clinical and Translational Research for Usona Institute, and as Director of Research in Spiritual Health for Emory University Healthcare and as the Founding Director of the Center for Compassion Studies in the College of Social and Behavioral Sciences at the University of Arizona Dr. Raison is internationally recognized for his studies examining novel mechanisms involved in the development and treatment of major depression and other stress-related emotional and physical conditions, as well as for his work in identifying and examining novel somatic and behavioral treatments for depression and related conditions associated with reduced well-being. Dr. Raison received the Raymond Pearl Memorial Award from the Human Biology Association “in recognition of his contributions to our understanding of evolutionary biocultural origins of mental health and illness” and has been recognized as a “Faculty of Excellence” at University of Wisconsin-Madison. Dr. Raison’s book “The New Mind-Body Science of Depression” was published by W.W. Norton in 2017. 

Three Learning Objectives:

1. Describe evolutionary forces that have maintained genetic risk factors for depression in human populations.
2. Explain how inputs that signaled survival and reproductive success in ancient environments have been repeatedly accessed across human history to induce states of emotional and physical well-being and stress-resiliency.
3. Describe how biological/psychological processes employed by ancient practices are being repurposed as novel treatments for major depression and other stress-related conditions.
   

To register, email:  Lauren Haguewood at lehaguewood@saintfrancis.com

Dr. Joanna Steinglass: March 6th, 2018
"Neurobiology of the Persistence of Anorexia Nervosa: Why So Stuck?"

William K. Warren, Jr.  Frontiers in Neuroscience Lecture
Laureate Psychiatric Clinic and Hospital Conference Center
11:00am - 11:45 am    Registration and Lunch, lunch stops being served at 11:45 - no exceptions
12:00pm - 1:00pm     Program

Dr. Joanna Steinglass is the Florence Irving Associate Professor in Clinical Psychiatry and the Director of Translational Research in Eating Disorders at the Center for Eating Disorders at Columbia University Medical Center and the New York State Psychiatric Institute. Dr. Steinglass graduated from Amherst College and received her medical degree from Harvard Medical School. She completed her psychiatry training and an NIMH-sponsored research fellowship in eating disorders at Columbia University College of Physicians and Surgeons and New York State Psychiatric Institute. Dr. Steinglass has had NIMH and private foundation support since 2006. The focus of her work is both the cognitive neuroscience of anorexia nervosa, and the development of mechanism-based treatments.

Three Learning Objectives:
 

1. To understand the role of dietary restriction in anorexia nervosa
2. To provide information about treatment outcomes
3. To understand neural mechanisms of maladaptive behavior
   ​
   

To register, email:  Lauren Haguewood at lehaguewood@saintfrancis.com

The "Healthy Brains for a Healthy Oklahoma" lectures have been cancelled for the remainder of the Spring 2018 series, with the exception of Dr. Martin Paulus' update on the Adolescent Brain Cognitive Development (ABCD) study on April 26, 2018 at 6pm. We will send out a reminder prior to the event. 

The following lectures will be cancelled:
February 22, 2018: The Mindful Brain, Dr. Kyle Simmons
March 22, 2018: Training a Resilient Brain: TU Tough, Dr. Robin Aupperle
May 24, 2018: Being in Charge- Regulate Your Brain, Dr. Jerzy Bodurka

We sincerely apologize for any inconvenience.
If you would like to view past HBHOK lectures, please visit our LIBR YouTube channel.

Thank you for your attendance and support of the Healthy Brains for a Healthy OK lecture series. 

Sincerely, 
The LIBR Staff

The Laureate Institute for Brain Research (LIBR) is excited to announce the PLoS One publication of the 1st float study ever conducted in patients suffering from both anxiety and depression. 

This open-label trial from Dr. Justin Feinstein's Float Clinic and Research Center at LIBR in 50 patients provides an initial proof-of-principle study showing that 1-hour of float therapy can provide significant short-term relief from symptoms of stress and anxiety across a range of different conditions including Post-Traumatic Stress Disorder (PTSD), Panic Disorder, Agoraphobia, Social Anxiety Disorder, and Generalized Anxiety Disorder.  

More than resolving symptoms of mental illness, the experience greatly enhanced mental wellness, leaving patients in a peaceful serene state afterwards.  This mood-enhancing effect of floatation was especially notable given that most of the patients had comorbid depression. 

It is important to emphasize that this was an open-label study examining the short-term effects of floating.  We are now tracking the time course of these effects as well as studying whether or not there is evidence for long-term benefit following repeated practice.  

Dr. Joshua A. Gordon: February 20, 2018
"Challenges and Opportunities in Mental Health Research"

William K. Warren, Jr.  Frontiers in Neuroscience Lecture
Laureate Psychiatric Clinic and Hospital Conference Center
11:00am - 11:45 am    Registration and Lunch, lunch stops being served at 11:45 - no exceptions
12:00pm - 1:00pm     Program

Joshua A. Gordon, M.D., Ph.D. pursued a combined MD/PhD degree at the University of
California, San Francisco. Medical school coursework in psychiatry and neuroscience convinced
him that the greatest need, and greatest promise, for biomedical science was in these areas.
During his Ph.D. thesis with Dr. Michael Stryker, Dr. Gordon pioneered the methods necessary
to study brain plasticity in the mouse visual system.

Upon completion of the dual degree program at UCSF, Dr. Gordon went to Columbia University
for his Psychiatry residency and research fellowship because of the breadth and depth of the
research opportunities here. Working with Dr. Rene Hen, Dr. Gordon and colleagues studied the
role of the hippocampus, a brain structure known to be important for memory, in emotional
processes such as anxiety and depression. He joined the Columbia faculty in 2004 as an
Assistant Professor in the Department of Psychiatry.

Dr. Gordon’s research focuses on the analysis of neural activity in mice carrying mutations of
relevance to psychiatric disease. His lab studies genetic models of these diseases from an
integrative neuroscience perspective, focused on understanding how a given disease mutation
leads to a behavioral phenotype across multiple levels of analysis. To this end, he employs a
range of systems neuroscience techniques, including in vivo anesthetized and awake behaving
recordings and optogenetics, which is the use of light to control neural activity. His work has
direct relevance to schizophrenia, anxiety disorders, and depression.

Three learning objectives:
 

1. Understand the role of the NIMH in supporting neuroscience and psychiatry research.
2. Understand how neural circuit approaches hold promises for advancing understanding and novel treatments for mental illnesses.
3. Understand how computational approaches hold promises for advancing understanding and novel treatments for mental illnesses.

To register, email:  Lauren Haguewood at lehaguewood@saintfrancis.com

​Mark Hyman Rapaport, M.D.:  February 6, 2018
"The Impact of Peripheral Inflammation on Mood: The Mind and the Body are Connected”

William K. Warren, Jr.  Frontiers in Neuroscience Lecture
Laureate Psychiatric Clinic and Hospital Conference Center
11:00am - 11:45 am    Registration and Lunch, lunch stops being served at 11:45 - no exceptions
12:00pm - 1:00pm     Program

Mark Hyman Rapaport, MD is the Reunette W. Harris Professor and Chair of the Department of Psychiatry and Behavioral Sciences at Emory University School of Medicine in Atlanta, Georgia.   Before coming to Emory, he was the Polier Chair of the Department of Psychiatry at University of California, Los Angeles (UCLA).
​
A board-certified psychiatrist, Dr. Rapaport has written over 180 articles for such peer-reviewed publications as American Journal of Psychiatry, Biological Psychiatry, Journal of Clinical Psychiatry and Neuropsychopharmacology. He currently serves as Co-Editor and Chief of FOCUS: The Journal of Lifelong Learning in Psychiatry, published by American Psychiatric Publishing, Inc. and the American Psychiatric Association. Dr. Rapaport is a member of the American College of Psychiatrists, American Society of Clinical Psychopharmacology, Anxiety Disorders Association of America, the Psychiatric Research Society and the Collegium International Neuropsychopharmacology (CINP). He is a distinguished fellow of the American Psychiatric Association, the CINP, and the American College of Neuropsychopharmacology.  He is Past-President of the American Society of Clinical Psychopharmacology and the current President of the American Association of Chairs of Departments of Psychiatry. 

Learning objectives:
 

1. Present the rationale for postulation that peripheral inflammation impacts basic function
   
2. Review data about the impact of inflammation on neurotransmission systems
3. Describe the state of current immune modulating therapies as treatments for depression
   
   

To register, email:  Lauren Haguewood at lehaguewood@saintfrancis.com

UPDATE: CANCELLED DUE TO GOVERNMENT SHUTDOWN

​David Goldman, M.D.:  January 23, 2018
"Genetics of Addiction:  How Many Genes?”

William K. Warren, Jr.  Frontiers in Neuroscience Lecture
Laureate Psychiatric Clinic and Hospital Conference Center
11:00am - 11:45 am    Registration and Lunch, lunch stops being served at 11:45 - no exceptions
12:00pm - 1:00pm     Program

Dr. David Goldman has been Chief of the Laboratory of Neurogenetics since 1991 and is Acting Clinical Director of NIAAA. Dr. Goldman graduated cum laude from Yale University and magna cum laude from the University of Texas Medical Branch, Galveston where he was also a Resident in Psychiatry. He joined NIAAA in 1979, was an NIMH Clinical Associate 1980-1984, and rejoined NIAAA in 1985. He is a Fellow of the American College of Neuropsychopharmacology. He has won the NIH Director’s Award twice, and the James Isaacson Research Award of the International Society for Biological Research on Alcoholism.  Dr. Goldman is author of “Our Genes, Our Choices,” which won The British Medical Association top prize. Throughout his career, Dr. Goldman has focused on identifying genes that influence vulnerability to alcoholism, other addictions and other psychiatric diseases. He has authored over 400 papers, including several of the first “imaging genetics” studies in which genes were shown to alter brain function.  He and his group use genomic methods, including sequencing, genome wide association, epigenetic studies and gene-based measurement of ancestry. He has discovered inherited variants that alter molecular function and traced the effects of these variants through to complex behaviors in both humans and animal models. Several, for example a variant of catechol-O-methyltransferase, which he has named a “warrior/worrier gene” alters stress response and emotion but also cognition, and the gene effects are context-dependent and stronger on molecules and intermediate brain functions. Several of Dr. Goldman’s studies involve the use of well-defined founder populations, including Finland and Native American Indian communities. He discovered an HTR2B “to be or not to be” stop codon that can lead to severe impulsivity. This strongly functional variant of a neurotransmitter receptor is population specific, being common in Finns, and absent in others. Dr. Goldman’s studies have also taken advantage of the ability to control genetic and environmental factors in animal models, both for gene discovery and for validation of gene effects.

Learning objectives:
 

1. Understand heritability of addiction.                    
2. Define environmentality of addiction.
3. Know some genes influencing addictions.
   
   

To register, email:  Lauren Haguewood at lehaguewood@saintfrancis.com

The "Healthy Brains for a Healthy Oklahoma" lecture series on January 25th has been cancelled and will resume next month on February 22nd.

If you were looking forward to Dr. Sahib Khalsa's lecture, please visit our YouTube channel to view a past recording:

"When Food Rules the Brain"

​Pain is a common experience among human beings. It is estimated that more than 30% of Americans have some form of acute or chronic pain. The increase awareness of pain and its consequences has had some unfortunate consequences. In 2014 alone, U.S. retail pharmacies dispensed 245 million prescriptions for opioid pain relievers.

In this lecture Dr. Paulus will outline:
(1) How pain is generated?
(2) What brain and molecular processes contribute to the severity and intensity of pain?
(3) How opioids work and what the consequences are of long-term opioid use.
(4) Treatments for opioid addiction and alternative for pain management.

Alexander Bystritsky, M.D., Ph.D.: November 14th, 2017

"Low Intensity Focused Ultrasound Pulse:  A New Neuromodulation Technology.  Similarity and Differences with Other Neuromodulation Technologies”

William K. Warren, Jr.  Frontiers in Neuroscience Lecture
Laureate Psychiatric Clinic and Hospital Conference Center
11:00am - 11:45 am    Registration and Lunch, lunch stops being served at 11:45 - no exceptions
12:00pm - 1:00pm     Program

Professor Alexander Bystritsky, M.D., Ph.D. graduated from Pavlov Medical Institute (currently Pavlov Medical University) in St. Petersburg, Russia (former Soviet Union) with M.D. degree in 1977 and then his Ph.D. in Pharmacology in 1979.  In 1976 his paper won the Gold Medal for the Best Student Scientific Paper and Maria Petrova National Award in Neuroscience.
 
After he arrived to New York, he worked for one year as an Associate Researcher in the NYU Department of Psychiatry prior his admission to the NYU-Belleview residency program in Psychiatry. He completed his residency in 1985 and moved to UCLA as a Robert Wood Johnson Clinical Scholar. Dr. Bystritsky has been on the UCLA Faculty since 1987. He is currently a Professor of Psychiatry and Biobehavioral Sciences in Jane and Terry Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles where he directs the Anxiety Disorders Program and Targeted Brain Stimulation Program. Dr. Bystritsky published over 240 peer-reviewed papers, book chapters and short publications and has served as the PI and Co-PI on several NIH, foundations and industry sponsored grants. Over the years, he earned several honors and awards including OCD Foundation Research Award and Brain and Behavior Distinguished Investigator Award. He is also listed in the Best Doctors in America for the last 20 years. For several years, he was a Visiting Professor and a collaborator with Brigham and Women's Hospital Harvard Medical School in Boston, Massachusetts investigating Focused Ultrasound Pulsation effects on brain using fMRI. He has authored several patents on image-guided neuromodulation of brain neurons using Low Intensity Focused Ultrasound Pulsation (LIFUP). His current area of interest is neuroimaging guided brain stimulation. He the director of collaborative Targeted Brain Stimulation clinical and research program on image-guided DBS, rTMS, LIFUP and other neuromodulation techniques in Anxiety Disorders with the department of Neurosurgery at UCLA. He is Executive Director of Tiny Blue Dot Foundation. He is Founder and CEO Brainsonix Corporation, a start-up company producing LIFUP/MR compatible devices for research.

Learning objectives:

1.  Inform the learners about different neuromodulation techniques.
2.  Discuss similarity and differences with LIFUP.
3.  Discuss historical development of the LIPUP.
 
REGISTER TO ATTEND!
 
To register, email:  Lauren Haguewood at lehaguewood@saintfrancis.com

Dr. Justin Feinstein's talk will discuss float therapy, a brand new treatment for naturally reducing levels of stress and anxiety.  The presentation will provide an overview of this novel therapy, how it works, and how it can help individuals who suffer from stress and anxiety.

Justin Feinstein is a Clinical Neuropsychologist at the Laureate Institute for Brain Research and an Assistant Professor at the new Oxley College of Health Sciences at the University of Tulsa.  He received his PhD from the University of Iowa and completed his postdoctoral training at the California Institute of Technology.  His research examines how the human brain produces primal states of emotion, with an emphasis on the neuroscience of fear and treatments that alleviate anxiety.  His work has been published in a number of top scientific journals and has been featured in the popular press including the New York Times, TIME magazine, NPR, and New Scientist.  

​Dr. Feinstein serves as Director of the Float Clinic and Research Center (FCRC) at the Laureate Institute for Brain Research. The FCRC’s mission is to investigate the effects of floatation on both the body and the brain, as well as explore its potential as a therapeutic treatment for promoting mental health and healing in patients who suffer from anxiety.

 Gary Glover, Ph.D.: October 10th, 2017
"Neuromodulation and fMRI”

William K. Warren, Jr.  Frontiers in Neuroscience Lecture
Laureate Psychiatric Clinic and Hospital Conference Center
11:00am - 11:45 am    Registration and Lunch, lunch stops being served at 11:45 - no exceptions
12:00pm - 1:00pm     Program

Dr. Glover is Professor of Radiology, Biophysics and Neurosciences, Electrical Engineering and Psychology (by courtesy), and is Director of Radiological Sciences Laboratory (RSL) in the Department of Radiology as well as the Richard M. Lucas Center for Imaging.  He has extensive experience in virtually all aspects of diagnostic medical imaging dating back to 1975, and has been a pioneer in developing novel magnetic resonance imaging techniques for nearly 30 years and fMRI methods since 1992.  His group has pioneered the use of spiral k-space methods for fMRI and contributes to development of both acquisition and analysis technology in use by many investigators.  As director of the Lucas Center, Dr. Glover works with many scientists and their students in performing fMRI experiments and has vast experience in a broad field of cognitive neuroscience, but with particular emphasis on neuroimaging acquisition methods.  He mentors five of his own students and post docs as well as approximately 10 other students and junior faculty for whom he a secondary advisor, thesis reader or research consultant. 

Learning objectives:

1.  Discuss how Transcranial Magnetic Stimulation and Transcranial Electrical Stimulation can affect brain function.
2.  Identify ways to monitor the stimulation sites.
3.  Learn how to apply this technology for basic and clinical applications.
 
REGISTER TO ATTEND!
 
To register, email:  Lauren Haguewood at lehaguewood@saintfrancis.com
​